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ABSTRACT 
Recent discoveries show steady improvements in life expectancy during modern decades. 
Does this support that humans continue to live longer in future? We recently put forward 
the maximum survival tendency, as found in survival curves of industrialized countries, 
which is described by extended Weibull model with age-dependent stretched exponent. The 
maximum survival tendency suggests that human survival dynamics may possess its 
intrinsic limit, beyond which survival is inevitably forbidden. Based on such tendency, we 
develop the model and explore the patterns in the maximum lifespan limits from 
industrialized countries during recent three decades. This analysis strategy is simple and 
useful to interpret the complicated human survival dynamics. 
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1. INTRODUCTION 
Humans live longer now. Indeed the life expectancy and the observed maximum age 
at death have significantly increased during recent decades [1−5]. Such increase is mainly 
attributable to non-biological aspects such as the intricate interplay of advances in income, 
nutrition, education, sanitation, and medicine [6,7]. Biologists and gerontologists are 
hunting for a variety of useful ways to prolong life in animals, including mice and worms [8]. 
Their research suggests that human lifespan may be remarkably pliable [8]. Can the 
strategies for animals help humans live longer? So far it is not practical, useful, or ethical to 
extend healthy life merely by modifying human genes [9] or by restricting food intake [10]. 
The theoretical maximum lifespan (called ω) in humans is still a subject of considerable 
debate [6] and the life extension is one of  the great challenges in the 21st century [8]. Many 
scientists believe that human lifespan has an inherent upper limit, although they disagree on 
whether it is 85 or 100 or 150 [8]. The maximum human lifespan is generally postulated to 
be around 125 years [7,11,12], whereas the record of the oldest ages at death is increasing 
today [4]. Conventional analysis or theoretical model has not yet come up with a plausible 
explanation for this disagreement. 
Recently, based on extended Weibull model with age-dependent stretched exponent 
[13,14], we suggested a mathematical model for human survival dynamics, S(x) = 
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exp(–(x/α)β(x)), which denotes survival probability with characteristic life α and 
age-dependent exponent β(x), and showed maximum survival tendency, dS(x)/dx → 0 [15]. 
In this study, we further develop the model and explore the dynamic patterns with year and 
country in predicting human lifespan limits (ω) for industrialized countries during recent 
three decades: ω = 0.458q + 54.241 where the upper x-intercept q = h + (k/p)1/2 for the 
quadratic model β(x) = –p(x – h)2 + k (where p, h, and k are variable with year and country). 
We aim to examine the lifespan puzzle—whether human lifespan is approaching a limit or 
not. Our analysis strategy has practical implications for aging research in biology, medicine, 
statistics, economy, public policy, and culture. 
 
2. METHODS 
We examine the survival dynamics of Sweden female’s survival curves during recent 
three decades, from 1977 to 2007. The reliable demographic data were taken from the 
periodic life tables (1x1) at the Human Mortality Database (http://www.mortality.org). We 
analyze the survival curves by using a general expression of human survival probability 
(S(x)) as a function of age (x) [15]: 
 
))exp(-(x/S(x) (x)βα=  
 
Here, the characteristic life (α) corresponds to the specific age of S(α) = exp(–1) and the 
age-dependent stretched exponent (or beta function, β(x)) reflects the flexibility of the 
survival curve [15]. The survival function allows the cumulative hazard function M(x) (= 
–log S(x)) on a restricted range. The breakdown of the positivity of the hazard function m(x) 
(= ∂M(x)/∂x) enables us to estimate a maximum limitation of human lifespan. Intuitively, 
our survival model approximates the Gompertz model [16] with a linear expression for β(x) 
as well as the Weibull model [17] with a constant β(x) through an approximation of ‘log 
m(x) ∝ β(x)’. 
Figure 1 illustrates the evolution of the beta function β(x), which is a pure 
mathematical conversion of the survival probability S(x), for Swedish females from 1977 to 
2007. The smooth survival data points above 94-97 years were chosen for modeling the beta 
function (solid lines). Here the discontinuities of the beta curves (dashed lines) near the 
characteristic lives (around 85-90 years) are due to the mathematical feature of the suggested 
model [15]. Apparently the curvatures of the beta curves seem to become more “negative” 
at the highest ages and the vertex points move upward year by year. Such trends directly 
connote the emergence of the “maximum survival tendency” [15]. 
In principle, the age-dependent beta function originates from the “maximum survival 
tendency”, which is a fundamental biological feature of human survival dynamics by 
minimizing its death rate (dS(x)/dx → 0) [15]. The maximum survival tendency is 
characterized as a “negative” slope of the beta function as d2β(x)/dx2 < 0 for the phase of x 
> α. 
We find that a quadratic model, β(x) = –β0 + β1x –β2x2 (where β0, β1, β2 > 0), is 
appropriate to describe the maximum survival tendency from the modern survival curves for 
the highest ages (for x > α), as marked by the solid lines in Fig. 1. This agrees to our 
previous observation [15]. In this study, we modify the quadratic model for β(x) as: 
 
- 3 - 
khxp +−−= 2)((x)β  
 
Here the coefficient p (= β2 = (–1/2) d2β(x)/dx2) denotes the curvature of the quadratic 
curve and the vertex point ν(h, k) indicates the maximum value of the quadratic curve. The 
curvature and the vertex point give an upper x-intercept (Fig. 1), as can be defined as the 
“q” point: 
 
2/1)/( pkhq +=  
 
The quadratic beta function based on the maximum survival tendency can be entirely 
described by quantifying the ν(h, k) and the q points. 
 
3. RESULTS 
The intrinsic definition of β(x) and S(x) leads to a mathematical limitation of the 
survival age, beyond which none can be alive. The theoretical limitation of the maximum 
lifespan (ω) is determined at the specific age of β(x) = f(x) as seen in Fig. 1. Here f(x) is the 
mathematical constraint of β(x) as defined as f(x) = –xln(x/α) dβ(x)/dx [15]. This feature 
suggests that the ω value can be found between the ν(h, k) and the q points. 
We observe the evolution of the quadratic beta functions from the survival curves of 
Sweden females, as seen in Fig. 2. The p and the k parameters linearly increase by period 
(P): p = 6.8897×10–5 P – 0.1346 and k = 6.389×10–2 P – 116.581. By contrary, the h 
parameter does not significantly change (average ~ 95.482 years), obviously since 1985, as 
marked by the gray area in Fig. 2. The linear increases of the p and the k parameters 
indicate that the curvature of the quadratic function becomes more negative and the vertex 
point moves upward from 1977 to 2007. Our model suggests that the upper x-intercept 
(q-value) may significantly decrease by period, following the scaling of (k/p)1/2. The 
obtained q values (squares) well follow the trend line (solid line) which is estimated from the 
p and the k parameters. The parameter estimation for Sweden females is summarized at 
Table 1. The correlation coefficients (r2) between data and model are higher than 0.994, 
suggesting the feasibility of  the model. As a result, we see in Fig. 2 that the q parameters 
gradually decrease by period in Sweden female’s life tables during recent three decades. 
The most interesting observation is that the maximum lifespan limits (ω) have a 
linear relationship with the upper x-intercept (q) parameter, as clearly seen in Fig. 3. The 
high linearity between the ω and the q values is found for both cases of Sweden females 
(between 1977 and 2007) and modern industrialized countries (Austria, Belgium, Bulgaria, 
Canada, Czech, Denmark, England, Estonia, Finland, France, West Germany, Hungary, 
Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, Norway, Poland, Russia, 
Scotland, Slovenia, Spain, Sweden, Switzerland, and USA; for females between 2005 and 
2007). The parameter estimation for modern industrialized countries is summarized at 
Table 2. The correlation coefficients (r2) between data and model are higher than 0.954, 
suggesting again the feasibility of  the model. Interestingly, we find in Fig. 3 that the 
three-decade variation of Sweden female (squares) is similar to the national variation of the 
other countries (circles). This similarity suggests that the dataset of Sweden female can be 
indeed “representative” for human survival tendency as suggested [4]. In Fig. 3, we see that 
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the ω values for all the datasets linearly decrease as the q values decrease (r2 = 0.9445): 
 
241.54458.0 += qω  
 
It is interesting that the ω values shift toward ~125 years (close squares) for Sweden females 
during the latest decade from 1997 to 2007. 
 
4. DISCUSSION 
The overall evolutions of the q values (Fig. 2) and ω values (Fig. 3) suggest that the 
human lifespan would be reaching an upper limit. Our study implies that the observed 
maximum lifespan limit is able to continue to climb until it encounters a theoretical 
forbidden barrier of human lifespan, as suggested [18]. The life-extension strategies such as 
aggressive anti-aging therapies may allow more people to reach the limit of the natural 
human lifespan and thus the period of disease or senescence will be compressed against the 
natural barrier at the end of life, as expected [19,20]. 
The lifespan limit estimation may support current aging theories that presume the 
existence of the biological limit to human lifespan [21−23]. Based on our estimation, it is 
predictable that many countries will face increasing issues of aging populations, age-related 
diseases, and healthcare costs [8]. The rise of human longevity will accelerate the population 
growth rate [24] and probably the steady rise in the achieved maximum lifespan [4] or the 
life expectancy [25] will reduce in the coming half century. The forthcoming trends may 
cause an ethical issue on fair distribution of healthcare resources [26]. Aging research 
requires new approaches to figure out the complex biology of aging [27]. 
The feasibility of the model is further obtained through a mathematical verification 
[28]: our data exist between 0.4 < (ω/α)ln(ω/α) < 0.8, which are consistent with their 
mathematical expectation between 0.410986 and 0.829297. Another verification is obtained 
from mortality patterns, which are defined as μ(x) = –dlnS(x)/dx = d[(x/α)β(x)]/dx or ∫μ(x) = 
(x/α)β(x). For simplification one defines δ(x) = μ(x)/∫μ(x) = β(x)/x + ln(x/α)dβ(x)/dx. The 
point where the mortality curve starts to decline is obtained from δ(x)2 + dδ(x)/dx = 0 by 
solving dμ(x)/dx = 0. This condition can be tested by graphical analysis or numerical 
simulation. For instance, taking the parameters: α = 88.57223 years, β0 = 26.32347, β1 = 
0.78810, and β2 = 0.00409 from 2007 Swedish female’s data (Table 1), we obtain the point 
as ~111 years. Above that point, the mortality curve decreases and eventually reaches zero 
at the maximum lifespan ~122.86 years. With the quadratic pattern of  β(x), the mortality 
pattern tends to decrease after a plateau and ultimately approach zero, well matching typical 
human mortality patterns. These results show the feasibility of  the model. 
 
5. CONCLUSION 
To conclude, we develop a human survival dynamics model as S(x) = exp(–(x/α)β(x)) 
with β(x) = –p(x – h)2 + k (where p, h, and k are variable with year and country), and 
explore the pattern of  the parameters, q = h + (k/p)1/2 and ω = 0.458q + 54.241, which are 
useful in predicting human lifespan limits (ω). We show generality and feasibility of  the 
model for modern industrialized countries during recent three decades. Based on statistical 
approach, we suggest that human lifespan is approaching a true limit around 125 years. This 
estimate may shed light on the central puzzle in aging research: whether biological lifespan 
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limits exist or not. Our model and prediction method would be useful to assess the 
complicated human survival dynamics [29], which would be essential to study on biology, 
medicine, statistics, economy, public policy, and culture. 
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Figures and Tables 
 
 
Figure 1: The evolution of Sweden female’s survival curves (dashed lines) from 1977 to 
2007. The beta function β(x) is plotted as a conversion of the survival probability, S(x) = 
exp(–(x/α)β(x)), where the characteristic life α corresponds to the specific age of S(α) = 
exp(–1) and the age-dependent beta function β(x) reflects the flexibility of the survival curve. 
Apparently the β(x) curvature becomes more negative and the vertex point moves upward 
year by year from 1977 to 2007. The inset describes that the maximum lifespan (ω) is 
determined at the specific age of β(x) = f(x), which is defined as f(x) = –xln(x/α) dβ(x)/dx. 
This feature suggests that the ω value can be found between the vertex point “ν(h, k)” and 
the upper x-intercept “q” point. 
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Figure 2: The evolution of the quadratic beta function parameters estimated from Fig. 1. 
The p and the k parameters increase linearly by period, while the h parameter does not 
significantly change, obviously since 1985 (gray area). These evolutions lead to a gradual 
decrease of the q parameter by period, following the scaling of (k/p)1/2. 
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Figure 3: The linear relationship of the upper x-intercept q and the theoretical lifespan ω 
values. The three-decade variation (open and closed squares) for Sweden females is similar 
to the national variation (circles) for modern industrialized countries. Interestingly, the 
maximum lifespan ω values linearly decrease with the upper x-intercept q values at a rate of 
ω = 0.458q + 54.241. The ω values approach ~125 years for Sweden females during the 
latest decade from 1997 to 2007 (closed squares). 
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Table 1. Estimations for Sweden female survival datasets. 
 
Datasets α (yrs) β0 β1 β2 r2 h (yrs) k q (yrs) ω (yrs) 
2007 88.57223 26.32347 0.78810 0.00409 0.99915 96.34 11.64 149.70 122.86 
2005 88.52680 17.85141 0.61727 0.00325 0.99949 94.96 11.46 154.34 125.19 
2002 87.83450 19.58927 0.65550 0.00346 0.99872 94.73 11.46 152.27 123.75 
2000 87.81336 17.81521 0.60247 0.00314 0.99864 95.93 11.08 155.35 125.45 
1997 87.66873 17.06434 0.58731 0.00307 0.99541 95.65 11.02 155.58 125.59 
1995 87.34920 10.82163 0.46078 0.00245 0.99955 94.04 10.84 160.56 127.73 
1992 86.91140 12.47482 0.49175 0.00260 0.99857 94.57 10.78 158.95 126.81 
1990 86.53163 13.17982 0.50236 0.00265 0.99926 94.78 10.63 158.11 126.21 
1987 86.30050 9.860300 0.42559 0.00225 0.99820 94.58 10.26 162.12 128.30 
1985 85.86844 11.91555 0.46436 0.00243 0.99576 95.55 10.27 160.55 127.37 
1982 85.58855 2.065850 0.27060 0.00151 0.99858 89.60 10.06 171.21 132.05 
1980 85.06656 2.594650 0.27414 0.00150 0.99487 91.38 9.93 172.75 132.66 
1977 84.83856 2.584840 0.26922 0.00147 0.99463 91.57 9.74 172.98 132.95 
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Table 2. Estimations for international female survival datasets. 
 
Datasets α (yrs) r2 h (yrs) k q (yrs) ω (yrs) 
Austria (2005) 88.07717 0.99973 92.06 11.51 157.23 126.16 
Belgium (2006) 88.17957 0.99960 95.29 11.23 154.80 125.23 
Bulgaria (2005) 82.71487 0.95438 94.92 9.55 150.53 121.06 
Canada (2005) 88.93178 0.99963 100.00 10.56 157.10 127.34 
Czech (2006) 85.58519 0.99742 94.70 10.51 153.61 123.58 
Denmark (2006) 86.67277 0.98848 100.58 9.96 158.11 127.16 
England (2005) 87.57264 0.99952 96.30 10.45 162.70 129.24 
Estonia (2007) 85.47782 0.99604 95.36 9.79 165.86 129.85 
Finland (2007) 88.76823 0.99834 93.56 11.93 153.32 124.54 
France (2006) 90.37934 0.99963 95.20 11.72 159.00 128.33 
Germany (2006) 88.11166 0.99869 89.77 11.92 156.22 125.34 
Hungary (2005) 83.79004 0.99779 96.27 9.07 169.96 131.53 
Iceland (2006) 88.78873 0.99560 99.22 11.61 142.67 119.77 
Ireland (2006) 87.53789 0.99960 90.75 10.44 174.44 134.53 
Italy (2005) 89.22443 0.99977 92.76 11.62 159.09 127.66 
Japan (2006) 91.59045 0.99942 98.17 11.47 161.51 130.31 
Latvia (2007) 83.82117 0.99683 95.46 9.43 165.53 129.20 
Lithuania (2007) 84.63518 0.99738 97.72 9.82 153.30 123.59 
Netherlands (2006) 87.85314 0.99636 95.65 11.17 155.48 125.55 
Norway (2006) 88.49842 0.99951 94.48 11.57 154.52 125.19 
Poland (2007) 87.63163 0.99919 91.29 11.48 156.14 125.31 
Russia (2006) 81.29562 0.98645 98.59 8.61 155.26 123.63 
Scotland (2006) 86.15168 0.99884 100.50 9.49 159.68 127.78 
Slovenia (2006) 87.42881 0.99890 94.93 10.81 157.52 126.32 
Spain (2006) 89.47929 0.99946 89.37 11.89 163.90 129.74 
Sweden (2007) 88.57223 0.99915 96.34 11.64 149.70 122.86 
Switzerland (2006) 89.69486 0.99806 97.52 11.75 149.62 123.38 
USA (2005) 87.43102 0.99878 103.37 9.27 159.62 128.74 
 
